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The recognition and presentation of tumor-associated anti-
gens by cutaneous antigen-presenting cells (APe) may play 
an important role in the establishment of effective defense 
mechanisms against newly emerging tumors in the skin. Re-
cent data demonstrate the ability of I-A+ epidermal cells 
(Langerhans cells) to present tumor-associated antigens for 
the induction of protective tumor immunity and elicitation 
of delayed-type hypersensitivity against the murine spindle 
cell tumor, S 1509a. Furthermore, the local cytokine microen-
vironment in the vicinity of a cutaneous neoplasm may regu-
late the ability of resident epidermal APC to initiate and/or 
to elicit protective immunity against incipient cutaneous 
T he interactions between tumors and the host immune system have been subject to intense investigation over the past 20 years, and research performed by numer-ous investigators has demonstrated the ability of the immune system to recognize and to destroy tumor 
cells in vivo and in vitro (reviewed in [1]). These findings led to the 
now somewhat controversial concept that tumor growth in situ may 
be under immunologic control with immunocompetent cells con-
stantly screening the body for transformed cells and attacking them 
speci fically [2] . The potential relevance of this concept for cutane-
ous tumor biology is supported by the increased risk of skin cancer in 
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neoplasms. This article summarizes the effects of granulo-
cyte-macrophage/colony-stimulating factor (GM-CSF), in-
terleukin-la (IL-la), tumor necrosis factor-a (TNFa), trans-
forming growth. factor-fJ C~'GFfJ), and in~erferon-y (IFNy) 
on the modulation of antlgen presentatiOn by epidermal 
APe. Our data indicate that these cytokines significantly and 
differentially modify the ability of epidermal cells to present 
tumor-associated antigens and that their effects differ with 
regard to induction of primary immunity (sensitization) or 
elicitation of secondary immune responses. ] Invest Dermatol 
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immunosuppressed individuals [3]. The generation of tumor-spe-
cific immune effector cells that control tumor growth, however 
requires recognition an~ presentatiOl.l of tumor-associated antigen~ 
(T AA) by cutaneous anttgen-presentmg cells (APC) both to induce 
and to elicit antitumor immunity [4]. Furthermore, the local cyto-
kine microenvironment in the vicinity of a cutaneous neoplasm may 
~e~~late the ability ?~ resident .epi?ermal .Langerhan.s cells (LC) to 
IJ1lt1ate and/or to eitCit protectIve Immumty agalJ1st IJ1cipient cuta-
neous neoplasms. This regulation of LC function by a network of 
cytokines has previously been studied primarily by investigating the 
effects of cytokines on the presentation of protein antigen to T-cell 
clones or of alloantigen in the mixed lymphocyte reaction [5 -13], 
but is also likely to be of great importance in the outcome of tumor 
immune responses. 
Effects of Cytokines on LC Function The ability of various 
cell types within the epidermis to produce cytokines in vivo and in 
vitro is well established (reviewed in [14]), and their effects on the 
Junction of epidermal LC is currently subject to investigation in a 
number oflaboratories. Granulocyte-macropha ge / colony-stimulat-
ing factor (GM-CSF), tumor necrosis factor (TNF)a, interferon 
(IFN)y, transforming growth factor (TGF)fJ, IL-l, IL-4, IL-8, IL-
10, and monocyte chemotactic and activating factor (MCAF) have 
so far been established to affect various types of APC (reviewed in 
[15 -18]). Less data exist concerning direct effects of these cytokines 
on the function of cutaneous LC. GM-CSF has been identified as 
the major factor that is responsible for the transition of LC from 
"fresh" to "cultured" LC, inducing prolonged survival of LC in 
culture, major histocompatability complex (MHC) class II expres-
sion, and differential modulation of other surface molecules on 
murine epidermal LC [5,7]. Additionally, murine epidermal LC 
develop enhanced ability to present alloantigen to unprimed T cells 
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during culture [8] , and either retain or down-regulate antigen pro-
cessing and presentation to primed T cells, depending on the mouse 
strain [9]. TNFa also prolongs LC viability in vitro, but it does not 
alter their surface marker characteristics or enhance LC-antigen 
presentation [6]; preliminary evidence suggests that it may down-
regulate cutaneous antigen presentation when given in vivo [10-
12]. TN Fa may also stimulate LC emigration into the draining 
lymph [19]. The effects of TNFa on cutaneous LC are, however, 
still controversial, especially with regard to its role as a mediator of 
the effects of UVR on LC [11,12]*. IL-l may also support survival 
of LC in culture, when applied in conjunction with GM-CSF [5], 
possibly via induction of GM-CSF production by keratinocytes [20] 
and up-regulates antigen presentation by monocytes and macro-
phages. IL-l has also been shown to affect LC migration in vivo 
l21J, to playa role in LC homing to the skin [22], and to alter LC 
surface marker expression [23]. Recent studies suggest a role for 
IL-l as a co-factor for LC stimulation of allogeneic T cells in the 
mixed epidermal cell-lymphocyte reaction (MELR) [24]. The ef-
fects of IFNy on LC on a functional level have not been thoroughly 
investigated so far. In humans, IFNy up-regulates MHC class II 
expression on LC and keratinocytes and also increases CD4, CD23, 
and other surface molecules on LC in vitro [25 - 27]. It has recently 
been suggested that IF Ny is involved in regulating LC surface mole-
cules that are necessary for the stimulation of allogeneic T cells in 
the MELR [24] . Furthermore, TGFpmay also affect antigen presen-
tation by LC; it has been demonstrated to inhibit antigen presenta-
tion by cultured, but not by fresh LC [13]. 
Effects of Cytokines on the Ability of LC to Present 
TAA Emerging from the hypothesis that immune surveillance 
mechanisms, which effectively control tumor growth in situ, exist 
within the skin and that the clinical appearance of skin tumors may 
already indicate a failure of these protective mechanisms, our aim 
was to evaluate the functional role of LC in defense mechanisms 
against cutaneous malignancies. In this context, we recently showed 
that murine I-A + epidermal cells are capable of presenting T AA for 
induction as well as elicitation of in vivo tumor immunity in a 
genetically restricted fashion, leadin~. t'? tU.m,?r rejec~ion an? the 
induction of delayed-type hypersensitivity m Immulllzed al1lmals 
[28]. In these stu?ies, naive ~ynge~eic mice were immunized three 
times at weekly mtervals with epidermal cells (Ee) (ennched for 
I-A + Le) that had been cultured in 50 U Iml GM - CSF for 18 hand 
then pulsed with T AA derived from the murine spindle cell tumor, 
S1509a (for detailed methods, see [28]). This resulted in protective 
immunity against subsequent tumor challenge, providing a model 
to study the conditions required for sensitization against TAA in an 
unprimed system by epidermal APC. Moreover, the ability of EC to 
elicit immunity against S1509a was also determined using a primed 
system by measuring the specific delayed-type hypersensitivity 
(DTH) response after footpad-i~ection of3-5 X 105 TAA-pulsed 
EC in mice that had' previously been immunized against S 1509a by 
repetitive subcutaneous injections with 106 killed tumor cells. TI1U~, 
the use of this experimental protocol enabled us both to study di-
rectly the ability of cytokines to modulate presentation ofTAA by 
epidermal APC and to generate some information about the effec.ts 
of cytokines on antigen presentation by LC in unprimed as well as 111 
primed systems. 
When EC were co-incubated in GM-CSF plus IL-la for 18 h, 
their ability to induce protective tumor immunity after pulse with 
T AA and subsequent injection into naive recipients was signifi-
cantly decreased compared to EC treated with GM-CSF alone. This 
inhibition was dose dependent. Thus, IL-la inhibited the induction 
of tumor immunity by tumor antigen-pulsed, GM-CSF-cultured 
epidermal APC. The inhibitory effect ofIL-la was, however, abro-
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Table I. 
GM-CSF 
TNFa 
IL-la 
IFNy 
TGFp 
Effects of Cytokines on LC Function in an Unprimed 
System: Induction of Tumor Immunity 
Augmentation 
Effects depend on the time point of exposu.re/reverses 
effect of GM-CSF 
Inhibition of GM-CSF effect/acts via induction of 
TNFa release 
No effect when given alone/inhibits effect of GM-CSF 
No inhibitory effect 
gated by the addition of neutralizing anti-TNFa monoclonal anti-
body t~ the 18-h culture period of EC before exposure to TAA, 
su&gestmg that IL-la down-regulates the ability of epidermal APC 
to mduce tumor immunity in this system via stimulation of TN Fa 
release: A~ summarized in Table I, a number of other cytokines also 
have slglllficant effects on the ability of LC to induce or to elicit 
immunity against the murine spindle cell tumor line, S1509a. Of 
n~te, some of thes~ cytokines appeared to act strikingly different 
With regard to their modulation of primary versus secondary im-
mune. resp~)11se~, and also the time point of exposure of LC to these 
~y.t,?kmes I.n Vitro affected their effects. For the ability of LC to 
~Illtlate .an Immu~e response against S1509a in unprimed ice, pre-
mcubatlon ofLC m GM-CSF was required, because fresh, untreated 
LC were unable to initiate significant immunity. IL-la, TNFa, 
IFNy, and TGFp were unable to substitute for GM-CSF in this 
system. These data support the current view that only GM-CSF-
cultured LC are able to present antigen to unprimed T cells [6,7]. 
TGFp had no effects on tumor antigen presentation by LC, despite 
its inhibitory functions on other APC. TNFa, IL-la, and IFNy 
were found to inhibit the immunostimulatory effect of GM-CSF on 
LC, because co-incubation of these cytokines with GM-CSF inhib-
ited or abrogated the GM-CSF-induced functional transition of 
:'fresh". to "cultured" LC with regard to this system. Subsequent 
mcubatlon of GM-CSF -cultured EC in TN Fa reversed this func-
tional transition ofLC. TNFa appeared to affect the ability ofLC to 
effectively encounter the tumor antigen, because exposure to TNFa 
after TAA-pulse had no inhibitory effect. Furthermore, the ability 
of fresh or GM-CSF-cultured LC to elicit an antitumor DTH 
response in pre-immunized mice was augmented by incubation in 
TNFa (~abl~ II). Thus, ~NFa has contrary effects on LC antigen 
preSe?tatlOn.ll1 both u~pnmed and primed systems, demonstrating 
the dl.fferentlal regulation of vanous aspects of LC function by this 
cytokll1e. In the pnmed system, IL-la was found to inhibit elicita-
tion ,?f ~~H by 1.' AA-pulsed fresh or cultured LC, whereas IFNy 
only mlublted antigen presentation by fresh LC. 
Together, these data indicate that the local cytokine microenvi-
ro~~ent wit~in the skin may be of significant importance for the 
ablltty of reSident cutaneous APC to initiate and to elicit immune 
responses. This concep~ may be of great importance for the under-
standmg of. cutaneous Immune surveillance against incipient neo-
plasms and It also suggests that modulation of antigen presentation 
by LC .by ~xposure to different cytokine environments (inflamma-
tory skll1 diseases, UV -irradiation, migration ofLC from the skin to 
lymphoid organs, and so forth) may lead to differential effects on 
Table II. Effects of Cytokines on LC Function in a Primed 
System: Elicitatioll of Tumor Immunity 
TNFa 
IL-la 
TGFp 
IFNy 
Augmentation 
Inhibition 
No effect or slight augmentation 
Inhibition 
Augmentation 
Inhibition 
Augmentation 
No effect 
• ftC, freshly prepared L1ngcrhans cells. 
6 cLC, L1ngcrhans cells after culture in 50 U / ml GM-CSF for 18 h. 
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the generation of immunity or, perhaps tolerance through the skin 
immune system in vivo. 
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